{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:47:31Z","timestamp":1786985251056,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115822","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T18:54:00Z","timestamp":1699383240000},"page":"115822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["TrxR\/Trx inhibitor butaselen ameliorates pulmonary fibrosis by suppressing NF-\u03baB\/TGF-\u03b21\/Smads signaling"],"prefix":"10.1016","volume":"169","author":[{"given":"Yifan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2023.115822_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-018-0730-2","article-title":"Idiopathic pulmonary fibrosis: pathogenesis and management","volume":"19","author":"Sgalla","year":"2018","journal-title":"Respir. Res"},{"issue":"10082","key":"10.1016\/j.biopha.2023.115822_bib2","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2023.115822_bib3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","article-title":"Clinical course and prediction of survival in idiopathic pulmonary fibrosis","volume":"183","author":"Ley","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"126","key":"10.1016\/j.biopha.2023.115822_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1183\/09059180.00002512","article-title":"Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature","volume":"21","author":"Nalysnyk","year":"2012","journal-title":"Eur. Respir. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2023.115822_bib5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1183\/13993003.00958-2015","article-title":"Idiopathic pulmonary fibrosis: tracking the true occurrence is challenging","volume":"46","author":"Samet","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.biopha.2023.115822_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-021-01791-z","article-title":"Global incidence and prevalence of idiopathic pulmonary fibrosis","volume":"22","author":"Maher","year":"2021","journal-title":"Respir. Res"},{"key":"10.1016\/j.biopha.2023.115822_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2015.04.005","article-title":"Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy","volume":"152","author":"Spagnolo","year":"2015","journal-title":"Pharm. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2023.115822_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2213-2600(18)30502-2","article-title":"Lung transplantation for idiopathic pulmonary fibrosis","volume":"7","author":"George","year":"2019","journal-title":"Lancet Respir. Med"},{"key":"10.1016\/j.biopha.2023.115822_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107798","article-title":"Idiopathic pulmonary fibrosis: Disease mechanisms and drug development","volume":"222","author":"Spagnolo","year":"2021","journal-title":"Pharm. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2023.115822_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1440-1843.2003.00523.x","article-title":"The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats","volume":"9","author":"Li","year":"2004","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.biopha.2023.115822_bib11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/resp.13024","article-title":"Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions","volume":"22","author":"Galli","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.biopha.2023.115822_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.rmed.2017.07.062","article-title":"Therapeutic targets in idiopathic pulmonary fibrosis","volume":"131","author":"Kolb","year":"2017","journal-title":"Respir. Med"},{"issue":"8","key":"10.1016\/j.biopha.2023.115822_bib13","first-page":"807","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy, The Lancet","volume":"8","author":"George","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.biopha.2023.115822_bib14","doi-asserted-by":"crossref","first-page":"6175964","DOI":"10.1155\/2020\/6175964","article-title":"Pulmonary fibrosis in COVID-19 survivors: predictive factors and risk reduction strategies","volume":"2020","author":"Ojo","year":"2020","journal-title":"Pulm. Med"},{"key":"10.1016\/j.biopha.2023.115822_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-pathol-012513-104706","article-title":"Pathogenesis of idiopathic pulmonary fibrosis","volume":"9","author":"Wolters","year":"2014","journal-title":"Annu Rev. Pathol."},{"issue":"7835","key":"10.1016\/j.biopha.2023.115822_bib16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2023.115822_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: pathogenesis, etiology and regulation","volume":"2","author":"Wilson","year":"2009","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115822_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.toxlet.2013.03.009","article-title":"Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-kappaB dependant TGF-beta activation: a biphasic experimental study","volume":"219","author":"Chitra","year":"2013","journal-title":"Toxicol. Lett."},{"issue":"7","key":"10.1016\/j.biopha.2023.115822_bib19","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J. Exp. Med"},{"issue":"6","key":"10.1016\/j.biopha.2023.115822_bib20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/jphp.13077","article-title":"Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4\/p65 and TGF-beta1\/Smad2\/3 pathway","volume":"71","author":"Jia","year":"2019","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.biopha.2023.115822_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","article-title":"Inflammation and immunity in IPF pathogenesis and treatment","volume":"147","author":"Heukels","year":"2019","journal-title":"Respir. Med"},{"key":"10.1016\/j.biopha.2023.115822_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/164_2020_393","article-title":"Effects of mammalian thioredoxin reductase inhibitors","volume":"264","author":"Arner","year":"2021","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.biopha.2023.115822_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-pharmtox-052220-102509","article-title":"Thioredoxin reductase inhibition for cancer therapy","volume":"62","author":"Gencheva","year":"2022","journal-title":"Annu Rev. Pharm. Toxicol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115822_bib24","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.bmc.2012.04.033","article-title":"Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy","volume":"20","author":"He","year":"2012","journal-title":"Bioorg. Med Chem."},{"issue":"8","key":"10.1016\/j.biopha.2023.115822_bib25","doi-asserted-by":"crossref","DOI":"10.5246\/jcps.2017.08.067","article-title":"Butaselen and cisplatin synergistically inhibit human cancer cells proliferation","volume":"26","author":"Zou","year":"2017","journal-title":"J. Chin. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.115822_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.redox.2017.09.014","article-title":"Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity","volume":"14","author":"Zheng","year":"2018","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115822_bib27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1631\/jzus.B1700219","article-title":"Novel thioredoxin reductase inhibitor butaselen inhibits tumorigenesis by down-regulating programmed death-ligand 1 expression","volume":"19","author":"Zou","year":"2018","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.biopha.2023.115822_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.690170","article-title":"Therapeutic effects of an inhibitor of thioredoxin reductase on liver fibrosis by inhibiting the transforming growth factor-beta1\/smads pathway","volume":"8","author":"Jiao","year":"2021","journal-title":"Front Mol. Biosci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115822_bib29","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2023.115822_bib30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.biopha.2016.06.040","article-title":"Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation","volume":"83","author":"Zheng","year":"2016","journal-title":"Biomed. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2023.115822_bib31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharm. Rev."},{"issue":"20","key":"10.1016\/j.biopha.2023.115822_bib32","doi-asserted-by":"crossref","first-page":"8207","DOI":"10.1074\/jbc.M116.768101","article-title":"A positive feedback loop between Pim-1 kinase and HBP1 transcription factor contributes to hydrogen peroxide-induced premature senescence and apoptosis","volume":"292","author":"Wang","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.biopha.2023.115822_bib33","doi-asserted-by":"crossref","first-page":"12688","DOI":"10.1074\/jbc.M116.714147","article-title":"HBP1-mediated regulation of p21 protein through the Mdm2\/p53 and TCF4\/EZH2 pathways and its impact on cell senescence and tumorigenesis","volume":"291","author":"Chen","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"D1","key":"10.1016\/j.biopha.2023.115822_bib34","doi-asserted-by":"crossref","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","article-title":"The reactome pathway knowledgebase 2022","volume":"50","author":"Gillespie","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2023.115822_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.freeradbiomed.2018.11.030","article-title":"The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen","volume":"131","author":"Zheng","year":"2019","journal-title":"Free Radic. Biol. Med"},{"issue":"1","key":"10.1016\/j.biopha.2023.115822_bib36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4049\/jimmunol.176.1.603","article-title":"NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription","volume":"176","author":"Lee","year":"2006","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115822_bib37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","article-title":"Simple method of estimating severity of pulmonary fibrosis on a numerical scale","volume":"41","author":"Ashcroft","year":"1988","journal-title":"J. Clin. Pathol."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2023.115822_bib38","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1513\/AnnalsATS.201410-448MG","article-title":"Mechanisms of alveolar epithelial injury, repair, and fibrosis","volume":"12","author":"Chambers","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"12","key":"10.1016\/j.biopha.2023.115822_bib39","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.202010-3832OC","article-title":"Saracatinib, a selective src kinase inhibitor, blocks fibrotic responses in preclinical models of pulmonary fibrosis","volume":"206","author":"Ahangari","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"4","key":"10.1016\/j.biopha.2023.115822_bib40","doi-asserted-by":"crossref","first-page":"L693","DOI":"10.1152\/ajplung.90446.2008","article-title":"Modulation of epidermal growth factor receptor binding to human airway smooth muscle cells by glucocorticoids and beta2-adrenergic receptor agonists","volume":"296","author":"Kassel","year":"2009","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115822_bib41","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1164\/rccm.201707-1497OC","article-title":"Protein tyrosine phosphatase-N13 promotes myofibroblast resistance to apoptosis in idiopathic pulmonary fibrosis","volume":"198","author":"Bamberg","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.biopha.2023.115822_bib42","doi-asserted-by":"crossref","first-page":"L1164","DOI":"10.1152\/ajplung.00220.2017","article-title":"IPF lung fibroblasts have a senescent phenotype","volume":"313","author":"Alvarez","year":"2017","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115822_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7150\/ijms.21881","article-title":"Dexamethasone down-regulates osteocalcin in bone cells through leptin pathway","volume":"15","author":"Chen","year":"2018","journal-title":"Int J. Med Sci."},{"key":"10.1016\/j.biopha.2023.115822_bib44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.steroids.2015.07.006","article-title":"Variance of spinal osteoporosis induced by dexamethasone and methylprednisolone and its associated mechanism","volume":"102","author":"Ren","year":"2015","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.biopha.2023.115822_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248957","article-title":"The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT","volume":"16","author":"Zou","year":"2021","journal-title":"PLoS One"},{"issue":"26","key":"10.1016\/j.biopha.2023.115822_bib46","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","article-title":"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis","volume":"184","author":"Wendisch","year":"2021","journal-title":"Cell"},{"issue":"28","key":"10.1016\/j.biopha.2023.115822_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1983","article-title":"Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis","volume":"6","author":"Adams TS","year":"2020","journal-title":"Sci. Adv."},{"issue":"12","key":"10.1016\/j.biopha.2023.115822_bib48","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","article-title":"Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis","volume":"199","author":"Reyfman","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"19","key":"10.1016\/j.biopha.2023.115822_bib49","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.biopha.2023.115822_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281295","article-title":"Factors associated with dose reduction of pirfenidone in patients with idiopathic pulmonary fibrosis: A study based on real-world clinical data","volume":"18","author":"Kim","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115822_bib51","doi-asserted-by":"crossref","first-page":"1025947","DOI":"10.3389\/fphar.2022.1025947","article-title":"Clinical outcomes of dose modification during pirfenidone treatment for IPF: A nationwide post-marketing surveillance study","volume":"13","author":"Kang","year":"2022","journal-title":"Front Pharm."},{"issue":"12","key":"10.1016\/j.biopha.2023.115822_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123229","article-title":"Long-Term safety of antifibrotic drugs in IPF: a real-world experience","volume":"10","author":"Levra","year":"2022","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.biopha.2023.115822_bib53","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/08971900211008625","article-title":"Adherence, persistence, and effectiveness in real life. Multicenter long-term study on the use of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"35","author":"Santoleri","year":"2022","journal-title":"J. Pharm. Pr."},{"issue":"4","key":"10.1016\/j.biopha.2023.115822_bib54","first-page":"2385","article-title":"Dexamethasone combined with berberine is an effective therapy for bleomycin-induced pulmonary fibrosis in rats","volume":"18","author":"Li","year":"2019","journal-title":"Exp. Ther. Med"},{"issue":"9","key":"10.1016\/j.biopha.2023.115822_bib55","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1164\/rccm.200209-982OC","article-title":"Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury","volume":"168","author":"Hoshino","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"3","key":"10.1016\/j.biopha.2023.115822_bib56","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.toxlet.2013.08.004","article-title":"Suppression of thioredoxin system contributes to silica-induced oxidative stress and pulmonary fibrogenesis in rats","volume":"222","author":"Zhu","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2023.115822_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2020.103461","article-title":"Sodium tanshinone IIA sulfonate attenuates silica-induced pulmonary fibrosis in rats via activation of the Nrf2 and thioredoxin system","volume":"80","author":"Zhu","year":"2020","journal-title":"Environ. Toxicol. Pharm."},{"key":"10.1016\/j.biopha.2023.115822_bib58","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.freeradbiomed.2022.07.020","article-title":"Thioredoxin reductase selenoproteins from different organisms as potential drug targets for treatment of human diseases","volume":"190","author":"Gencheva","year":"2022","journal-title":"Free Radic. Biol. Med"},{"issue":"5","key":"10.1016\/j.biopha.2023.115822_bib59","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.freeradbiomed.2011.11.034","article-title":"Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent","volume":"52","author":"Wang","year":"2012","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.biopha.2023.115822_bib60","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cbi.2017.07.020","article-title":"Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells","volume":"275","author":"Zheng","year":"2017","journal-title":"Chem. Biol. Inter."},{"issue":"4","key":"10.1016\/j.biopha.2023.115822_bib61","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3350\/cmh.2022.0068","article-title":"Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- kappaB signaling pathways","volume":"28","author":"Lee","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115822_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-021-02345-1","article-title":"Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome","volume":"4","author":"Kim","year":"2021","journal-title":"Commun. Biol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223016207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223016207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:26:24Z","timestamp":1777577184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223016207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":62,"alternative-id":["S0753332223016207"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115822","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TrxR\/Trx inhibitor butaselen ameliorates pulmonary fibrosis by suppressing NF-\u03baB\/TGF-\u03b21\/Smads signaling","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115822"}}